Top compounds associated with response to METTL9


Feature Type Standardized
Nominal ANOVA
mRNA Docetaxel CTRPv2 pan-cancer AAC -0.091 0.06
mRNA Nutlin-3a (-) GDSC1000 pan-cancer AAC -0.065 0.07
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.063 0.07
mRNA Methotrexate FIMM pan-cancer AAC -0.23 0.07
mRNA S-Trityl-L-cysteine FIMM pan-cancer AAC -0.31 0.07
mRNA ciclosporin CTRPv2 pan-cancer AAC 0.069 0.07
mRNA BRD-K71781559 CTRPv2 pan-cancer AAC -0.069 0.08
mRNA WZ-1-84 GDSC1000 pan-cancer AAC -0.09 0.08
mRNA JQ-1:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.058 0.08
mRNA BRD-K29313308 CTRPv2 pan-cancer AAC 0.065 0.08
Download CSV